Healthcare conglomerates with insurance and pharmacy benefit arms are favoring biosimilars made by overseas subsidiaries.
Noah Tong is a Staff Writer covering health payers at Corridor Business Journal. He focuses on themes related to health and wellness, healthcare administration, and consumer health, often exploring topics such as private and public health, drugs and medication, and the latest health news. Noah's work has been featured in notable publications including FierceHealth, RamaOnHealthcare, Modern Healthcare, and Crain's Chicago Business.












